1. Home
  2. HUMAW vs PNTG Comparison

HUMAW vs PNTG Comparison

Compare HUMAW & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMAW
  • PNTG
  • Stock Information
  • Founded
  • HUMAW 2004
  • PNTG 2019
  • Country
  • HUMAW United States
  • PNTG United States
  • Employees
  • HUMAW 220
  • PNTG N/A
  • Industry
  • HUMAW Biotechnology: Pharmaceutical Preparations
  • PNTG Medical/Nursing Services
  • Sector
  • HUMAW Health Care
  • PNTG Health Care
  • Exchange
  • HUMAW Nasdaq
  • PNTG Nasdaq
  • Market Cap
  • HUMAW N/A
  • PNTG 805.7M
  • IPO Year
  • HUMAW N/A
  • PNTG N/A
  • Fundamental
  • Price
  • HUMAW $0.50
  • PNTG $24.59
  • Analyst Decision
  • HUMAW
  • PNTG Buy
  • Analyst Count
  • HUMAW 0
  • PNTG 6
  • Target Price
  • HUMAW N/A
  • PNTG $35.17
  • AVG Volume (30 Days)
  • HUMAW 14.2K
  • PNTG 281.3K
  • Earning Date
  • HUMAW 03-21-2025
  • PNTG 08-05-2025
  • Dividend Yield
  • HUMAW N/A
  • PNTG N/A
  • EPS Growth
  • HUMAW N/A
  • PNTG 40.99
  • EPS
  • HUMAW N/A
  • PNTG 0.76
  • Revenue
  • HUMAW N/A
  • PNTG $748,167,000.00
  • Revenue This Year
  • HUMAW N/A
  • PNTG $25.01
  • Revenue Next Year
  • HUMAW N/A
  • PNTG $8.19
  • P/E Ratio
  • HUMAW N/A
  • PNTG $32.31
  • Revenue Growth
  • HUMAW N/A
  • PNTG 30.04
  • 52 Week Low
  • HUMAW $1.18
  • PNTG $21.18
  • 52 Week High
  • HUMAW $1.34
  • PNTG $37.13
  • Technical
  • Relative Strength Index (RSI)
  • HUMAW N/A
  • PNTG 35.08
  • Support Level
  • HUMAW N/A
  • PNTG $25.05
  • Resistance Level
  • HUMAW N/A
  • PNTG $26.17
  • Average True Range (ATR)
  • HUMAW 0.00
  • PNTG 1.00
  • MACD
  • HUMAW 0.00
  • PNTG -0.28
  • Stochastic Oscillator
  • HUMAW 0.00
  • PNTG 5.62

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Share on Social Networks: